FCRL5 and autoimmune disease: While FCRL5 has mostly been characterized in B cells and B cell lymphomas [47], [48], polymorphisms have also been reported to be associated with autoimmune diseases such as ankylosing spondylitis [49], suggesting an immunoregulatory role [47].